RWA
Redhawk Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-411
| Closed | -$205K | – | 352 |
|
|
2025
Q1 | $205K | Buy |
+411
| New | +$205K | 0.03% | 286 |
|
|
2024
Q4 | – | Sell |
-352
| Closed | -$218K | – | 328 |
|
|
2024
Q3 | $218K | Buy |
+352
| New | +$218K | 0.03% | 290 |
|
|
2023
Q4 | – | Sell |
-406
| Closed | -$205K | – | 314 |
|
|
2023
Q3 | $205K | Buy |
+406
| New | +$205K | 0.07% | 192 |
|
|
2022
Q1 | – | Sell |
-813
| Closed | -$542K | – | 263 |
|
|
2021
Q4 | $542K | Buy |
813
+29
| +4% | +$19.3K | 0.14% | 103 |
|
|
2021
Q3 | $448K | Buy |
784
+186
| +31% | +$106K | 0.12% | 119 |
|
|
2021
Q2 | $302K | Sell |
598
-30
| -5% | -$15.2K | 0.07% | 187 |
|
|
2021
Q1 | $286K | Sell |
628
-18
| -3% | -$8.2K | 0.07% | 179 |
|
|
2020
Q4 | $301K | Sell |
646
-29
| -4% | -$13.5K | 0.08% | 181 |
|
|
2020
Q3 | $298K | Buy |
675
+34
| +5% | +$15K | 0.09% | 166 |
|
|
2020
Q2 | $232K | Buy |
+641
| New | +$232K | 0.08% | 165 |
|
|
2019
Q3 | – | Sell |
-106
| Closed | -$31K | – | 404 |
|
|
2019
Q2 | $31K | Buy |
+106
| New | +$31K | 0.01% | 287 |
|